Your browser doesn't support javascript.
loading
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma.
Wang, Stacie S; Pandey, Kirti; Watson, Katherine A; Abbott, Rebecca C; Mifsud, Nicole A; Gracey, Fiona M; Ramarathinam, Sri H; Cross, Ryan S; Purcell, Anthony W; Jenkins, Misty R.
Afiliação
  • Wang SS; The Walter and Eliza Hall Institute of Medical Research, Immunology Division, Parkville, VIC 3052, Australia.
  • Pandey K; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • Watson KA; The University of Melbourne, Department of Medical Biology, Parkville, VIC 3052, Australia.
  • Abbott RC; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Mifsud NA; The Walter and Eliza Hall Institute of Medical Research, Immunology Division, Parkville, VIC 3052, Australia.
  • Gracey FM; The Walter and Eliza Hall Institute of Medical Research, Immunology Division, Parkville, VIC 3052, Australia.
  • Ramarathinam SH; The University of Melbourne, Department of Medical Biology, Parkville, VIC 3052, Australia.
  • Cross RS; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Purcell AW; Myrio Therapeutics, 6-16 Joseph St, Blackburn North, Melbourne, VIC 3130, Australia.
  • Jenkins MR; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Mol Ther Oncolytics ; 30: 167-180, 2023 Sep 21.
Article em En | MEDLINE | ID: mdl-37674626
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália